Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014
SHANGHAI, China, June 28, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a
POSTS IN CATEGORY
SHANGHAI, China, June 28, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a
BRIDGEWATER, N.J., June 28, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (ต่อไปนี้จะเรียกว่า “บริษัท” หรือ
BRIDGEWATER, N.J., June 25, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or
BRIDGEWATER, N.J., June 26, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (ต่อไปนี้จะเรียกว่า “บริษัท” หรือ
Capping Off FCB’s Record-Breaking Year NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) — The Cannes
BRIDGEWATER, N.J., June 26, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (ต่อไปนี้จะเรียกว่า “บริษัท” หรือ
BRIDGEWATER, N.J., June 25, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Launch of Proposed Public Offering in the United States
Orphalan Announces Positive Top Line Data with Trientine Tetrahydrochloride for Maintenance Patients with Wilson’s Disease
Copyright 2024 © bruneitribune.com All rights Reserved.